Page last updated: 2024-10-31

mitoxantrone and Ataxia Telangiectasia

mitoxantrone has been researched along with Ataxia Telangiectasia in 1 studies

Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.

Ataxia Telangiectasia: An autosomal recessive inherited disorder characterized by choreoathetosis beginning in childhood, progressive CEREBELLAR ATAXIA; TELANGIECTASIS of CONJUNCTIVA and SKIN; DYSARTHRIA; B- and T-cell immunodeficiency, and RADIOSENSITIVITY to IONIZING RADIATION. Affected individuals are prone to recurrent sinobronchopulmonary infections, lymphoreticular neoplasms, and other malignancies. Serum ALPHA-FETOPROTEINS are usually elevated. (Menkes, Textbook of Child Neurology, 5th ed, p688) The gene for this disorder (ATM) encodes a cell cycle checkpoint protein kinase and has been mapped to chromosome 11 (11q22-q23).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Smith, PJ1
Blunt, NJ1
Desnoyers, R1
Giles, Y1
Patterson, LH1

Other Studies

1 other study available for mitoxantrone and Ataxia Telangiectasia

ArticleYear
DNA topoisomerase II-dependent cytotoxicity of alkylaminoanthraquinones and their N-oxides.
    Cancer chemotherapy and pharmacology, 1997, Volume: 39, Issue:5

    Topics: Anthraquinones; Antineoplastic Agents; Ataxia Telangiectasia; Cell Line; Cell Line, Transformed; Cel

1997